Lithuanian Prostate Diagnostics Implementation Guide
0.0.1 - ci-build Lithuania flag

Lithuanian Prostate Diagnostics Implementation Guide, published by Lithuanian Medical Library. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7LT/ig-lt-prostate/ and changes regularly. See the Directory of published versions

: Prostate - mpMRI Sequence Type

Active as of 2026-03-31

Raw xml | Download


<ValueSet xmlns="http://hl7.org/fhir">
  <id value="prostate-sequence-type"/>
  <language value="en"/>
  <text>
    <status value="extensions"/>
    <div xml:lang="en" lang="en"><hr/><p><b>English</b></p><hr/><p class="res-header-id"><b>Generated Narrative: ValueSet prostate-sequence-type</b></p><a name="prostate-sequence-type"> </a><a name="hcprostate-sequence-type"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Language: en</p></div><ul><li>Include these codes as defined in <a href="http://dicom.nema.org/resources/ontology/DCM"><code>http://dicom.nema.org/resources/ontology/DCM</code></a><span style="opacity: 0.5" title="Version is not explicitly stated. When building this specification, the most recent version 2025.3.20250714 has been used"> version ⏿2025.3.20250714</span><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="http://tx.fhir.org/r5/ValueSet/DCM#DCM-110805">110805</a></td><td>T2 Weighted MR Signal Intensity</td><td>Signal intensity of a T2 Weighted MR image. T2 Weighted image contrast state is approached by imaging with a TR long compared to tissue T1 (to reduce T1 contribution to image contrast) and a TE between the longest and shortest tissue T2s of interest.</td></tr><tr><td><a href="http://tx.fhir.org/r5/ValueSet/DCM#DCM-113043">113043</a></td><td>Diffusion weighted</td><td>Values are derived by calculation of the diffusion weighting.</td></tr><tr><td><a href="http://tx.fhir.org/r5/ValueSet/DCM#DCM-113041">113041</a></td><td>Apparent Diffusion Coefficient</td><td>Values are derived by calculation of the apparent diffusion coefficient. This concept may be used for the diffusion coefficient of various different models, e.g., mono-exponential (ADCm), kurtosis (ADCk), stretched-exponential (ADCs).The &quot;apparent&quot; appellation is because the diffusion images from which the ADC is computed may also be affected by T2 contrast (T2 &quot;shine-through&quot;), so this concept is distinguished from a &quot;pure&quot; diffusion coefficient that is not so affected.</td></tr><tr><td><a href="http://tx.fhir.org/r5/ValueSet/DCM#DCM-110816">110816</a></td><td>T1 Weighted Dynamic Contrast Enhanced MR Signal Intensity</td><td>Signal intensity of a T1 Weighted Dynamic Contrast Enhanced MR image. A T1 Weighted Dynamic Contrast Enhanced MR image reflects the dynamics of diffusion of the exogenous contrast media from the blood pool into the extra vascular extracellular space (EES) of the brain at a rate determined by the blood flow to the tissue, the permeability of the Brain Blood Barrier (BBB), and the surface area of the perfusing vessels.</td></tr></table></li></ul></div>
  </text>
  <url value="https://tx.hl7.lt/fhir/ValueSet/prostate-sequence-type"/>
  <version value="0.0.1"/>
  <name value="ProstateSequenceTypeVS"/>
  <title value="Prostate - mpMRI Sequence Type"/>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2026-03-31T08:54:25+00:00"/>
  <publisher value="Lithuanian Medical Library"/>
  <contact>
    <name value="Lithuanian Medical Library"/>
    <telecom>
      <system value="url"/>
      <value value="https://medicinosnk.lt"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="info@medicinosnk.lt"/>
    </telecom>
  </contact>
  <description
               value="Sequence/image types used in prostate mpMRI scoring (DICOM terminology)."/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="LT"/>
    </coding>
  </jurisdiction>
  <compose>
    <include>
      <system value="http://dicom.nema.org/resources/ontology/DCM"/>
      <concept>
        <code value="110805"/>
        <display value="T2 Weighted MR Signal Intensity"/>
      </concept>
      <concept>
        <code value="113043"/>
        <display value="Diffusion weighted"/>
      </concept>
      <concept>
        <code value="113041"/>
        <display value="Apparent Diffusion Coefficient"/>
      </concept>
      <concept>
        <code value="110816"/>
        <display
                 value="T1 Weighted Dynamic Contrast Enhanced MR Signal Intensity"/>
      </concept>
    </include>
  </compose>
</ValueSet>